Up next

Dr. Peter McCullough - C19 Vaccine causing Blood Clots

13 Views· 02/03/23
Hiro M
Hiro M
71 Subscribers
71

⁣Dr. Peter McCullough PhD - C19 Vaccine is causing Blood Clots.
FDA published article says 11% are fatal.
⁣We've seen extensive blood clots, such as 14 inches long. These blood clots or thrombi are not dissolving with standard blood thinner.
It has been reported that blood clots are becoming ⁣amylogenic (⁣rubber or fiber like).
Watch: ⁣https://clikview.com/v/mVswn5?....ref=8965352386375caa

⁣⁣About Dr. Peter McCullough
⁣Dr. Peter McCullough has been among the world’s most prominent and vocal advocate for early outpatient treatment of SARS-CoV-2 (COVID-19) Infection in order to prevent hospitalization and death. He is an internist, cardiologist, epidemiologist, and Professor of Medicine at Texas A & M College of Medicine, Dallas, TX USA.


Dr. McCullough has broadly published on a range of topics in medicine with over 1000 publications and over 600 citations in the National Library of Medicine. His works include the “Interface between Renal Disease and Cardiovascular Illness” in Braunwald’s Heart Disease Textbook. Dr. McCullough is a recipient of the Simon Dack Award from the American College of Cardiology and the International Vicenza Award in Critical Care Nephrology for his scholarship and research. Dr. McCullough is a founder and current president of the Cardiorenal Society of America, an organization dedicated to bringing cardiologists and nephrologists together to work on the emerging problem of cardiorenal syndromes. He is the editor-in-chief of Cardiorenal Medicine, Reviews in Cardiovascular Medicine, and senior associate editor of the American Journal of Cardiology. He serves on the editorial boards of multiple specialty journals. He has served as member or chair of data safety monitoring boards of 24 randomized clinical trials.


Since the outset of the pandemic, Dr. McCullough has been a leader in the medical response to the COVID-19 disaster and has published “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection” the first synthesis of sequenced multidrug treatment of ambulatory patients infected with SARS-CoV-2 in the American Journal of Medicine and subsequently updated in Reviews in Cardiovascular Medicine. He has 47 peer-reviewed publications on the infection and has commented extensively on the medical response to the COVID-19 crisis in TheHill and on FOX NEWS Channel.

Show more

 0 Comments Sort By